Tuberculosis (TB) is the leading cause of human death worldwide due to Mycobacterium tuberculosis (Mtb)
infection. Mtb
infection can cause macrophage pyroptosis. PERK, as a signaling pathway
protein on the endoplasmic reticulum, plays an important role in
infectious diseases. It is not clear whether PERK is involved in the regulation of pyroptosis of macrophages during Mtb
infection. In this study, Bacillus Calmette-Guerin (BCG)
infection resulted in high expression of
pro-caspase-1, caspase-1 p20, GSDMD-N, and p-PERK in the THP-1 macrophage, being downregulated with the pre-treatment of
GSK2656157, a PERK inhibitor. In addition,
GSK2656157 inhibited the secretion of IL-1β and
IL-18, cell content release, and cell membrane
rupture, as well as the decline in cell viability induced by BCG
infection. Similarly,
GSK2656157 treatment downregulated the expressions of
pro-caspase-1, caspase-1 p20, caspase-11, IL-1β p17,
IL-18 p22, GSDMD, GSDMD-N, and p-PERK, as well as reducing fibrous tissue
hyperplasia, inflammatory infiltration, and the bacterial load in the lung tissue of C57BL/6J mice infected with BCG. In conclusion, the inhibition of PERK alleviated pyroptosis induced by BCG
infection, which has an effect of resisting
infection.